The Course of COVID-19 and Long COVID: Identifying Risk Factors among Patients Suffering from the Disease before and during the Omicron-Dominant Period
Pathogens · 2024
DOI: 10.3390/pathogens13030267 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathogens, 2024. Verfasst von Mateusz Babicki und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Family Medicine, Wroclaw Medical University, 51-141 Wroclaw, Poland. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Medical Center of Postgraduate Education., Medical Center of Postgraduate Education.
Abstract (Originalsprache)
SARS-CoV-2 has acquired many mutations that influence the severity of COVID-19’s course or the risk of developing long COVID. In 2022, the dominant SARS-CoV-2 variant was Omicron. This study aimed to compare the course of COVID-19 in the periods before and during the dominance of the Omicron variant. Risk factors for developing long COVID were also assessed. This study was based on stationary visits of patients after COVID-19 and follow-up assessments after 3 months. Clinical symptoms, comorbidities, and vaccination status were evaluated in 1967 patients. Of the analyzed group, 1308 patients (66.5%) were affected by COVID-19 in the period before the Omicron dominance. The prevalence of long COVID was significantly lower among patients of the Omicron group (47.7% vs. 66.9%, p < 0.001). The risk of long COVID was higher for women (OR: 1.61; 95% CI: 1.31, 1.99]) and asthmatics (OR: 1.46; 95% CI: 1.03, 2.07]). Conclusively, infection during the Omicron-dominant period was linked to a lower risk of developing long COVID. Females are at higher risk of developing long COVID independent of the pandemic period. Individuals affected by COVID-19 in the Omicron-dominant period experience a shorter duration of symptoms and reduced frequency of symptoms, except for coughing, which occurs more often.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Family Medicine, Wroclaw Medical University, 51-141 Wroclaw, Poland.
- Department of Biomedicine and Experimental Surgery, Medical University of Lodz, Narutowicza 60, 90-136 Lodz, Poland.
- Department of Functional Genomics, Medical University of Lodz, Żeligowskiego 7/9, 90-752 Lodz, Poland.
- Department of Internal Diseases, Rehabilitation and Physical Medicine, Medical University of Lodz, 90-647 Lodz, Poland.
- Department of Internal Medicine and Geriatric Cardiology, Medical Centre for Postgraduate Education, 01-813 Warsaw, Poland.
- Department of Nephrology, Hypertension and Family Medicine, Medical University of Lodz, 90-549 Lodz, Poland.
ORCID-Profile: Mateusz Babicki, Damian Kołat, Żaneta Kałuzińska-Kołat, Joanna Kapusta, Agnieszka Mastalerz-Migas, Piotr Jankowski, Michał Chudzik
Förderung
- The Medical Center of Postgraduate Education.
- Medical Center of Postgraduate Education
Zitieren
APA
Babicki, M., Kołat, D., Kałuzińska-Kołat, Ż., Kapusta, J., Mastalerz-Migas, A., Jankowski, P., & Chudzik, M. (2024). The Course of COVID-19 and Long COVID: Identifying Risk Factors among Patients Suffering from the Disease before and during the Omicron-Dominant Period. Pathogens. https://doi.org/10.3390/pathogens13030267
Vancouver
Babicki M, Kołat D, Kałuzińska-Kołat Ż, Kapusta J, Mastalerz-Migas A, Jankowski P, et al. The Course of COVID-19 and Long COVID: Identifying Risk Factors among Patients Suffering from the Disease before and during the Omicron-Dominant Period. Pathogens. 2024. doi:10.3390/pathogens13030267
BibTeX
@article{Babicki2024,
author = {Babicki, Mateusz and Kołat, Damian and Kałuzińska-Kołat, Żaneta and Kapusta, Joanna and Mastalerz-Migas, Agnieszka and Jankowski, Piotr and Chudzik, Michał},
title = {The Course of COVID-19 and Long COVID: Identifying Risk Factors among Patients Suffering from the Disease before and during the Omicron-Dominant Period},
journal = {Pathogens},
year = {2024},
doi = {10.3390/pathogens13030267}
}
EUVIMED